These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 24170747)

  • 21. Sensor Life and Overnight Closed Loop: A Randomized Clinical Trial.
    Tauschmann M; Allen JM; Wilinska ME; Ruan Y; Thabit H; Acerini CL; Dunger DB; Hovorka R
    J Diabetes Sci Technol; 2017 May; 11(3):513-521. PubMed ID: 27837162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A fully artificial pancreas versus a hybrid artificial pancreas for type 1 diabetes: a single-centre, open-label, randomised controlled, crossover, non-inferiority trial.
    Tsoukas MA; Majdpour D; Yale JF; Fathi AE; Garfield N; Rutkowski J; Rene J; Legault L; Haidar A
    Lancet Digit Health; 2021 Nov; 3(11):e723-e732. PubMed ID: 34580055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target.
    Rossetti P; Quirós C; Moscardó V; Comas A; Giménez M; Ampudia-Blasco FJ; León F; Montaser E; Conget I; Bondia J; Vehí J
    Diabetes Technol Ther; 2017 Jun; 19(6):355-362. PubMed ID: 28459603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
    Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis of overnight closed-loop randomized studies in children and adults with type 1 diabetes: the Cambridge cohort.
    Kumareswaran K; Elleri D; Allen JM; Harris J; Xing D; Kollman C; Nodale M; Murphy HR; Amiel SA; Heller SR; Wilinska ME; Acerini CL; Evans ML; Dunger DB; Hovorka R
    J Diabetes Sci Technol; 2011 Nov; 5(6):1352-62. PubMed ID: 22226252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flexible insulin therapy with a hybrid regimen of insulin degludec and continuous subcutaneous insulin infusion with pump suspension before exercise in physically active adults with type 1 diabetes (FIT Untethered): a single-centre, open-label, proof-of-concept, randomised crossover trial.
    Aronson R; Li A; Brown RE; McGaugh S; Riddell MC
    Lancet Diabetes Endocrinol; 2020 Jun; 8(6):511-523. PubMed ID: 32445738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Faster Compared With Standard Insulin Aspart During Day-and-Night Fully Closed-Loop Insulin Therapy in Type 1 Diabetes: A Double-Blind Randomized Crossover Trial.
    Dovc K; Piona C; Yeşiltepe Mutlu G; Bratina N; Jenko Bizjan B; Lepej D; Nimri R; Atlas E; Muller I; Kordonouri O; Biester T; Danne T; Phillip M; Battelino T
    Diabetes Care; 2020 Jan; 43(1):29-36. PubMed ID: 31575640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes.
    Ware J; Allen JM; Boughton CK; Wilinska ME; Hartnell S; Thankamony A; de Beaufort C; Schierloh U; Fröhlich-Reiterer E; Mader JK; Kapellen TM; Rami-Merhar B; Tauschmann M; Nagl K; Hofer SE; Campbell FM; Yong J; Hood KK; Lawton J; Roze S; Sibayan J; Bocchino LE; Kollman C; Hovorka R;
    N Engl J Med; 2022 Jan; 386(3):209-219. PubMed ID: 35045227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An integrated multivariable artificial pancreas control system.
    Turksoy K; Quinn LT; Littlejohn E; Cinar A
    J Diabetes Sci Technol; 2014 May; 8(3):498-507. PubMed ID: 24876613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia.
    Breton M; Farret A; Bruttomesso D; Anderson S; Magni L; Patek S; Dalla Man C; Place J; Demartini S; Del Favero S; Toffanin C; Hughes-Karvetski C; Dassau E; Zisser H; Doyle FJ; De Nicolao G; Avogaro A; Cobelli C; Renard E; Kovatchev B;
    Diabetes; 2012 Sep; 61(9):2230-7. PubMed ID: 22688340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fully Closed-Loop Glucose Control Compared With Insulin Pump Therapy With Continuous Glucose Monitoring in Adults With Type 1 Diabetes and Suboptimal Glycemic Control: A Single-Center, Randomized, Crossover Study.
    Boughton CK; Hartnell S; Lakshman R; Nwokolo M; Wilinska ME; Ware J; Allen JM; Evans ML; Hovorka R
    Diabetes Care; 2023 Nov; 46(11):1916-1922. PubMed ID: 37616583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial.
    Daly AB; Boughton CK; Nwokolo M; Hartnell S; Wilinska ME; Cezar A; Evans ML; Hovorka R
    Nat Med; 2023 Jan; 29(1):203-208. PubMed ID: 36631592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Closed-Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes.
    Stewart ZA; Wilinska ME; Hartnell S; Temple RC; Rayman G; Stanley KP; Simmons D; Law GR; Scott EM; Hovorka R; Murphy HR
    N Engl J Med; 2016 Aug; 375(7):644-54. PubMed ID: 27532830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of a portable bihormonal closed-loop system to control glucose excursions at home under free-living conditions for 48 hours.
    van Bon AC; Luijf YM; Koebrugge R; Koops R; Hoekstra JB; DeVries JH
    Diabetes Technol Ther; 2014 Mar; 16(3):131-6. PubMed ID: 24224750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility study of automated overnight closed-loop glucose control under MD-logic artificial pancreas in patients with type 1 diabetes: the DREAM Project.
    Nimri R; Atlas E; Ajzensztejn M; Miller S; Oron T; Phillip M
    Diabetes Technol Ther; 2012 Aug; 14(8):728-35. PubMed ID: 22853723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Day-and-Night Closed-Loop Insulin Delivery in a Broad Population of Pregnant Women With Type 1 Diabetes: A Randomized Controlled Crossover Trial.
    Stewart ZA; Wilinska ME; Hartnell S; O'Neil LK; Rayman G; Scott EM; Barnard K; Farrington C; Hovorka R; Murphy HR
    Diabetes Care; 2018 Jul; 41(7):1391-1399. PubMed ID: 29535135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of the Diabeloop closed-loop system to improve glycaemic control in patients with type 1 diabetes exposed to gastronomic dinners or to sustained physical exercise.
    Hanaire H; Franc S; Borot S; Penfornis A; Benhamou PY; Schaepelynck P; Renard E; Guerci B; Jeandidier N; Simon C; Hannaert P; Xhaard I; Doron M; Huneker E; Charpentier G; Reznik Y
    Diabetes Obes Metab; 2020 Mar; 22(3):324-334. PubMed ID: 31621186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of microdialysis-based continuous glucose monitoring to drive real-time semi-closed-loop insulin infusion.
    Freckmann G; Jendrike N; Pleus S; Buck H; Bousamra S; Galley P; Thukral A; Wagner R; Weinert S; Haug C
    J Diabetes Sci Technol; 2014 Nov; 8(6):1074-80. PubMed ID: 25205589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of artificial pancreas in the non-adult population: A systematic review and network meta-analysis.
    Karageorgiou V; Papaioannou TG; Bellos I; Alexandraki K; Tentolouris N; Stefanadis C; Chrousos GP; Tousoulis D
    Metabolism; 2019 Jan; 90():20-30. PubMed ID: 30321535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Efficacy of Basal Rate and Carbohydrate Ratio Learning Algorithm for Closed-Loop Insulin Delivery (Artificial Pancreas) in Youth with Type 1 Diabetes in a Diabetes Camp.
    Palisaitis E; El Fathi A; Von Oettingen JE; Krishnamoorthy P; Kearney R; Jacobs P; Rutkowski J; Legault L; Haidar A
    Diabetes Technol Ther; 2020 Mar; 22(3):185-194. PubMed ID: 31596127
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.